129 related articles for article (PubMed ID: 38263707)
21. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients.
Phatak PD; Ryan DH; Cappuccio J; Oakes D; Braggins C; Provenzano K; Eberly S; Sham RL
Blood Cells Mol Dis; 2002; 29(1):41-7. PubMed ID: 12482402
[TBL] [Abstract][Full Text] [Related]
23. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria.
Brissot P; Moirand R; Jouanolle AM; Guyader D; Le Gall JY; Deugnier Y; David V
J Hepatol; 1999 Apr; 30(4):588-93. PubMed ID: 10207799
[TBL] [Abstract][Full Text] [Related]
24. Factors influencing disease phenotype and penetrance in HFE haemochromatosis.
Rochette J; Le Gac G; Lassoued K; Férec C; Robson KJ
Hum Genet; 2010 Sep; 128(3):233-48. PubMed ID: 20607553
[TBL] [Abstract][Full Text] [Related]
25. Haemochromatosis and HFE gene.
Moirand R; Deugnier Y; Brissot P
Acta Gastroenterol Belg; 1999; 62(4):403-9. PubMed ID: 10692770
[TBL] [Abstract][Full Text] [Related]
26. The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testing.
Watkins S; Thorburn D; Joshi N; Neilson M; Joyce T; Spooner R; Cooke A; Mills PR; Morris AJ; Stanley AJ
Eur J Gastroenterol Hepatol; 2008 May; 20(5):379-83. PubMed ID: 18403938
[TBL] [Abstract][Full Text] [Related]
27. Hereditary Hemochromatosis Variant Associations with Incident Nonliver Malignancies: 11-Year Follow-up in UK Biobank.
Atkins JL; Pilling LC; Torti SV; Torti FM; Kuchel GA; Melzer D
Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1780-1787. PubMed ID: 35709753
[TBL] [Abstract][Full Text] [Related]
28. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
29. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
Press RD; Flora K; Gross C; Rabkin JM; Corless CL
Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
[TBL] [Abstract][Full Text] [Related]
30. Clinical Penetrance of Hereditary Hemochromatosis-Related End-Organ Damage of C282Y Homozygosity, A Newfoundland Experience.
Lim DR; Vidyasankar G; Phua C; Borgaonkar M
Clin Transl Gastroenterol; 2020 Nov; 11(11):e00258. PubMed ID: 33259166
[TBL] [Abstract][Full Text] [Related]
31. Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?
Cadet E; Capron D; Gallet M; Omanga-Léké ML; Boutignon H; Julier C; Robson KJ; Rochette J
J Med Genet; 2005 May; 42(5):390-5. PubMed ID: 15863667
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis.
Stickel F; Buch S; Zoller H; Hultcrantz R; Gallati S; Österreicher C; Finkenstedt A; Stadlmayr A; Aigner E; Sahinbegovic E; Sarrazin C; Schafmayer C; Braun F; Erhart W; Nothnagel M; Lerch MM; Mayerle J; Völzke H; Schaller A; Kratzer W; Boehm BO; Sipos B; D'Amato M; Torkvist L; Stal P; Arlt A; Franke A; Becker T; Krawczak M; Zwerina J; Berg T; Hinrichsen H; Krones E; Dejaco C; Strasser M; Datz C; Hampe J
Hum Mol Genet; 2014 Jul; 23(14):3883-90. PubMed ID: 24556216
[TBL] [Abstract][Full Text] [Related]
33. Expression of the HFE hemochromatosis gene in a community-based population of elderly women.
Rossi E; Kuek C; Beilby JP; Jeffrey GP; Devine A; Prince RL
J Gastroenterol Hepatol; 2004 Oct; 19(10):1150-4. PubMed ID: 15377292
[TBL] [Abstract][Full Text] [Related]
34. CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients.
Pelucchi S; Mariani R; Calza S; Fracanzani AL; Modignani GL; Bertola F; Busti F; Trombini P; Fraquelli M; Forni GL; Girelli D; Fargion S; Specchia C; Piperno A
Haematologica; 2012 Dec; 97(12):1818-25. PubMed ID: 22773607
[TBL] [Abstract][Full Text] [Related]
35. Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank.
Pilling LC; Tamosauskaite J; Jones G; Wood AR; Jones L; Kuo CL; Kuchel GA; Ferrucci L; Melzer D
BMJ; 2019 Jan; 364():k5222. PubMed ID: 30651232
[TBL] [Abstract][Full Text] [Related]
36. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
[TBL] [Abstract][Full Text] [Related]
37. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver.
Blanc JF; De Ledinghen V; Bernard PH; de Verneuil H; Winnock M; Le Bail B; Carles J; Saric J; Balabaud C; Bioulac-Sage P
J Hepatol; 2000 May; 32(5):805-11. PubMed ID: 10845668
[TBL] [Abstract][Full Text] [Related]
38. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.
Merryweather-Clarke AT; Cadet E; Bomford A; Capron D; Viprakasit V; Miller A; McHugh PJ; Chapman RW; Pointon JJ; Wimhurst VL; Livesey KJ; Tanphaichitr V; Rochette J; Robson KJ
Hum Mol Genet; 2003 Sep; 12(17):2241-7. PubMed ID: 12915468
[TBL] [Abstract][Full Text] [Related]
39. Association of Genetic Variant Linked to Hemochromatosis With Brain Magnetic Resonance Imaging Measures of Iron and Movement Disorders.
Loughnan R; Ahern J; Tompkins C; Palmer CE; Iversen J; Thompson WK; Andreassen O; Jernigan T; Sugrue L; Dale A; Boyle MET; Fan CC
JAMA Neurol; 2022 Sep; 79(9):919-928. PubMed ID: 35913729
[TBL] [Abstract][Full Text] [Related]
40. Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282Y.
Barton JC; Barton JC; Acton RT
BMC Gastroenterol; 2023 Apr; 23(1):137. PubMed ID: 37118679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]